Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
CLEAR (YOU) has pulled back from recent highs into oversold territory while fundamentals - membership growth, revenue beats and rising free cash flow - remain intact. This trade idea proposes a disciplined buy-the-dip entry at $46.50 with a $60 target over a swing window as travel demand and identity-verification adoption continue to accelerate.
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, announced that the Japanese Patent Office has granted a patent covering NeuroThera's proprietary pharmacological combination involving 4-aminophenol derivatives and N-acylethanolamines. The patent protects formulations aimed at enhancing the analgesic and antipyretic effects of 4…
Openlane's stock slid 5.3% in pre-market trading following the announcement that Ignition Acquisition Holdings LP, a fund advised by Apax Partners, is selling 8,000,000 shares in an underwritten secondary offering. The shares were converted from Series A Convertible Preferred Stock in May 2026. Openlane will not receive proceeds from the sale and h…
Autonomix Medical, Inc. announced the successful completion of its Good Laboratory Practice (GLP) preclinical study, demonstrating positive safety and performance outcomes for its nerve-targeted treatment platform. This milestone supports upcoming FDA submission efforts and marks significant progress in the company’s development of innovative medic…
Scienture Holdings announces the commercial launch and initial order fulfillment of REZENOPY™, a 10 mg naloxone hydrochloride nasal spray, targeting the $143 million U.S. naloxone market. The product is backed by national sales efforts, payer coverage for 100 million lives, and access to over 5,000 healthcare facilities, aiming to expand institutio…
Safe Pro Group Inc. has entered a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Engineer Research and Development Center to jointly develop AI-powered image analysis technologies leveraging uncrewed aerial systems. The partnership aims to enhance situational awareness solutions for military and civil uses, focusing on th…
Dow (DOW) looks compelling after management’s cost actions and persistent demand in key chemical markets. The shares trade at roughly $30.75 with a market cap near $22.7B and free cash flow of $1.46B, supporting a 4.7% dividend and room for multiple expansion. We upgrade to a tactical long and recommend entering at $30.75, targeting $37.00 over the…
Antalpha Platform Holding Company, a Nasdaq-listed fintech firm specializing in digital asset financing for the Web3 industry, announced it will release its Q2 2026 financial results on August 19, 2026, prior to the market open. The management team will host a conference call to discuss the results and address investor questions.
Binah Capital Group, a NASDAQ-listed financial services company, announced its participation in the Sidoti Micro-Cap Virtual Conference scheduled for August 19-20, 2026. The company's CEO and CFO will present on August 20, sharing insights into Binah's hybrid-friendly platform that supports independent financial advisors (RIAs). The event webcast w…
Tvardi Therapeutics, a clinical-stage biopharmaceutical company listed on NASDAQ under the ticker TVRD, will host a webinar featuring Dr. Randy Longman to discuss the evolving treatment landscape of ulcerative colitis (UC) and new data on their investigational oral small molecule drug TTI-109 targeting STAT3. The Phase 1 healthy volunteer results s…
Agencia Comercial Spirits Ltd, listed on NASDAQ, announced that its subsidiary has entered into a five-year technical services agreement worth $10 million with a regional provider to support networking integration for its AI computing infrastructure deployment in Indonesia. This initiative is a co-primary business alongside its established premium …
PodcastOne reported record first quarter fiscal 2027 revenue of $16.1 million, an 8% year-over-year increase, alongside an adjusted EBITDA of $1.6 million, up 172% from the prior year. The company expanded its creator portfolio and strengthened its market position by achieving its highest-ever Podtrac ranking (#6), surpassing major competitors incl…
Century Therapeutics reported strong Q2 2026 results highlighting significant progress in its iPSC-derived cell therapy pipeline, including a positive pre-IND meeting with the FDA for CNTY-813 targeting type 1 diabetes functional cure and ongoing preparations for CNTY-308 clinical trials in B-cell diseases. The company established Phase 1 manufactu…
High Roller Technologies, Inc., a publicly traded company on the NYSE, appoints Thomas Scaria, CFA, as its first Chief Product Officer to spearhead the development and launch of its ROLR prediction markets platform. The new role reflects the company's strategic focus on accelerating product innovation and market expansion in the real-money online g…
Avalyn Pharma announced the completion of patient enrollment for its global Phase 2b MIST trial evaluating AP01 for progressive pulmonary fibrosis. The trial overenrolled with 398 patients, and topline data are expected in late 2027. The company is also progressing Phase 2 AURA trial for AP02 and plans to initiate Phase 1 for AP03 by end of 2026. A…
LiqTech International, Inc. announced its second quarter 2026 financial results, reporting a decline in revenue to $4.4 million and net loss of $3.1 million. The company revised its full-year 2026 revenue guidance to $20-23 million, reflecting delays in a major Water for Energy project. LiqTech highlighted strong growth in Commercial Pool and Marin…
NeOnc Technologies announced encouraging topline results from its Phase 2a study of intranasal NEO100 in patients with recurrent IDH1-mutant high-grade glioma. The study met its primary endpoint, with a six-month progression-free survival rate of 48.9%, significantly exceeding the 20% benchmark. Median overall survival was 26.09 months, with no maj…
Solana Company (NASDAQ: HSDT), a digital asset treasury and infrastructure firm focusing on the Solana ecosystem, announced it will release its second quarter 2026 operating results on August 14, 2026, followed by a management conference call to discuss the results and provide a business update.
SunScout Holding Limited, a New Zealand-based clean technology company specializing in autonomous solar-powered robotic mowers, has priced its initial public offering of 3.1 million shares at $5.00 each, raising $15.5 million before expenses. The shares will be dual-listed on NYSE American and NYSE Texas under the ticker SNSC. Proceeds will fund a …
Fusion Fuel Green PLC announced that its subsidiary BrightHy Solutions has completed key execution milestones on two green hydrogen projects in Southern Europe, including the completion of the FEED package for a 15 MW green hydrogen production facility and successful factory acceptance tests for a hydrogen refueling station. These advances position…
Tri Pointe Homes, one of the largest homebuilders in the U.S., has been named to the 2026 PEOPLE Companies That Care list for the fourth consecutive year, underscoring its dedication to fostering a supportive workplace culture, employee empowerment, sustainable business practices, and community engagement. This recognition is based on extensive emp…
Haoxi Health Technology Limited announced a reverse share split of its Class A and Class B ordinary shares at a ratio of 1-for-20 effective August 14, 2026. The split will reduce the number of outstanding shares and increase the share price accordingly on Nasdaq, where the stock trades under ticker HAO. No fractional shares will be issued; fraction…
Madrigal Pharmaceuticals, a biopharmaceutical company specializing in treatments for metabolic dysfunction-associated steatohepatitis (MASH), announced the appointment of Dr. John C. Reed to its Board of Directors. Dr. Reed brings extensive leadership experience in drug discovery and development from his roles at Johnson & Johnson, Sanofi, and Roch…
Bone Biologics Corporation announces the extension of the validated shelf life of its rhNELL-1 protein to 32 months, improving flexibility in manufacturing, storage, and distribution as it advances its pilot clinical study for spinal fusion applications. This milestone supports operational efficiency and supply chain flexibility for the company's l…
Twin Disc, Inc. (NASDAQ: TWIN) announced the release date for its fiscal 2026 fourth-quarter earnings, set for August 20, 2026, along with a webcast and conference call to discuss the results. The company manufactures marine and heavy-duty off-highway power transmission equipment, serving multiple markets including marine, energy, military, and ind…
